[ Price : $8.95]
Novo Nordisk reports favorable Phase 2 data for its investigational dual-action obesity and diabetes drug amycretin, showing signi...[ Price : $8.95]
A new study of FDA advisory committee meetings reveals that a substantial portion of public speakers support drug approval, and ma...[ Price : $8.95]
FDA releases the form FDA-483 with six observations from an inspection at the Catalent Indiana sterile drug manufacturing facility...[ Price : $8.95]
U.S. House and Senate health committee leaders express concern about a new FDA review pilot program because it appears designed to...[ Price : $8.95]
FDA investigators cite Molecular PharmaGroup, an outsourcing facility in New Providence, N.J., for multiple sterility and quality-...[ Price : $8.95]
FDA issues an early alert warning about a potentially high-risk defect in certain Fresenius Kabi Ivenix large volume pump primary ...[ Price : $8.95]
Johnson & Johnson discontinues its Auτonomy Phase 2b Alzheimers study after interim data showed its experimental antibody pos...[ Price : $8.95]
FDA cites PharmaTher over alleged misleading promotional claims for its generic ketamine.